7-Eleven Agrees to $4.5 Million Settlement in FTC Antitrust Case

The Epoch Times
7-Eleven will pay $4.5 million to the FTC to settle a lawsuit alleging violations of a 2018 antitrust consent order.

Summary

7-Eleven and its parent company have agreed to a $4.5 million settlement with the Federal Trade Commission (FTC) due to alleged violations of a 2018 consent order. The FTC stated on December 8th that this penalty is the largest civil penalty ever collected in an FTC case involving a prior-notice violation and the largest negotiated settlement in the FTC Bureau of Competition’s history. The case centers around antitrust concerns, with the FTC alleging that 7-Eleven did not adhere to the stipulations outlined in the previous agreement.

(Source:The Epoch Times)

WBRZ

$5M lawsuit claims Disney's California theme parks illegally collect facial recognition data

CP24 Toronto

Judge approves class action lawsuit launched by Quebec TV personality

The Bradenton Times

Maryland reaches $4.1M settlement with homebuilder in sediment pollution case

Tekedia

Tether Invests on LemFi to Accelerate Stablecoin Settlement Flow in Africa and Asia

Headtopics

President Trump, Family, and Businesses Shielded from Pending Tax Audits as Part of DOJ Settlement

Bitcoin News

Evernorth Highlights XRP’s ‘Actual Story’ Beyond JPMorgan Settlement Attention

Punch

SEC fixes June 1 for T+1 settlement cycle transition

Firstpost

Why is Trump’s new IRS settlement triggering allegations of ‘self-dealing’?

Syracuse Ny Local News

Government to permanently drop tax claims against Trump family as part of lawsuit settlement

USA TODAY

Disney sued over facial recognition at California theme parks

New York Post

Disneyland targeted in class-action lawsuit claiming new program is violating guests' privacy

Bangor Daily News

Journalists sue tech giants over 'stolen' voices for AI training

The Mercury News

Disneyland hit with $5 million lawsuit over use of facial recognition technology

Devdiscourse

UPDATE 4-Takeda engaged in antitrust scheme to delay generic constipation drug, US jury finds

The Japan Times

Takeda engaged in antitrust scheme to delay generic constipation drug: U.S. jury